Medicines Discovery Catapult (MDC) and We Share Ventures have embarked on a joint venture, piloting an innovative funding model aimed at opening new funding opportunities for early-stage medicines discovery.
The facility, which was closed in 2020, includes the multi-million pound cyclotron, one of only a handful in the UK.
The BioIndustry Association (BIA), the Wellcome Sanger Institute and Medicines Discovery Catapult (MDC) have today launched Genomics Nation.
The Catapult Network is ready to play a key role in implementing the strategy and supporting industrial sectors to innovate.
The CEOs of all nine Catapults came together at a special event held in the High Value Manufacturing Catapult’s MTC in Coventry to sign the shared Inclusivity in Innovation Charter.
Chief.AI, in partnership with Medicines Discovery Catapult (MDC), has launched the first no-code, pay as you go, AI platform for drug discovery.
Medicines Discovery Catapult (MDC) is proud to announce an extension to its talented workforce.
The Alderley Park facility received the award for its integral role in establishing the Lighthouse Laboratory network.
The UK’s centre for therapeutics innovation, Medicines Discovery Catapult (MDC), has received a £5 million grant to build a Translational Research Facility in Infectious Disease on its Alderley Park site.
See how we can help support you with your next drug discovery project.
Speak to us
